QUESTION 1For questions 1 – 6:Given treatments:A: cost $4,000, 60% survivalB: cost: $7,000, 63% survivalC: cost $11,000, 61% survivalD: cost $10,000, 74% survivalNo intervention: 11% survival1. Which treatment is obviously dominated?3 pointsQUESTION 2What is the ACER for Treatment D?3 pointsQUESTION 3How do we interpret an ACER number for a particular treatment?3 pointsQUESTION 4What is the ICER from treatment A to B?3 pointsQUESTION 5Which treatment is marginally dominated?3 pointsQUESTION 6Which treatments comprise the Cost Effectiveness Frontier?3 pointsQUESTION 7What impact does insurance (or having more beneficial insurance) have on to the Cost effectiveness Frontier?3 pointsQUESTION 8What can we add to the CEF to turn this cost effectiveness tool into a Cost Benefit tool?3 pointsQUESTION 9Currently, Dywane’s probability of survival is 0.7 and his q value is 0.6. Assuming a discount factor of 0.91, what is his QALY? (rounded-off)3 pointsQUESTION 10IN YEAR 2, If the discount rate = 5% what is the discount factor?3 points